The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure

Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto; and Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological reviews 2007-04, Vol.87 (2), p.565
Hauptverfasser: Oliveira, Laerte, Costa-Neto, Claudio M, Nakaie, Clovis R, Schreier, Shirley, Shimuta, Suma I, Paiva, Antonio C. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 565
container_title Physiological reviews
container_volume 87
creator Oliveira, Laerte
Costa-Neto, Claudio M
Nakaie, Clovis R
Schreier, Shirley
Shimuta, Suma I
Paiva, Antonio C. M
description Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto; and Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil The most prevalent physiological effects of ANG II, the main product of the renin-angiotensin system, are mediated by the AT 1 receptor, a rhodopsin-like AGPCR. Numerous studies of the cardiovascular effects of synthetic peptide analogs allowed a detailed mapping of ANG II's structural requirements for receptor binding and activation, which were complemented by site-directed mutagenesis studies on the AT 1 receptor to investigate the role of its structure in ligand binding, signal transduction, phosphorylation, binding to arrestins, internalization, desensitization, tachyphylaxis, and other properties. The knowledge of the high-resolution structure of rhodopsin allowed homology modeling of the AT 1 receptor. The models thus built and mutagenesis data indicate that physiological (agonist binding) or constitutive (mutated receptor) activation may involve different degrees of expansion of the receptor's central cavity. Residues in ANG II structure seem to control these conformational changes and to dictate the type of cytosolic event elicited during the activation. 1 ) Agonist aromatic residues (Phe 8 and Tyr 4 ) favor the coupling to G protein, and 2 ) absence of these residues can favor a mechanism leading directly to receptor internalization via phosphorylation by specific kinases of the receptor's COOH-terminal Ser and Thr residues, arrestin binding, and clathrin-dependent coated-pit vesicles. On the other hand, the NH 2 -terminal residues of the agonists ANG II and [Sar 1 ]-ANG II were found to bind by two distinct modes to the AT 1 receptor extracellular site flanked by the COOH-terminal segments of the EC-3 loop and the NH 2 -terminal domain. Since the [Sar 1 ]-ligand is the most potent molecule to trigger tachyphylaxis in AT 1 receptors, it was suggested that its corresponding binding mode might be associated with this special condition of receptors. 1 The online version of this article has supplemental data.
doi_str_mv 10.1152/physrev.00040.2005
format Article
fullrecord <record><control><sourceid>pubmed_highw</sourceid><recordid>TN_cdi_highwire_physiology_physrev_87_2_565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17429042</sourcerecordid><originalsourceid>FETCH-LOGICAL-h208t-b8b9819bcd212c4665911167fa7c1d7fdf4a0560d91c947c8441f893a0191c773</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk7_gBeSe-nMST_SXJbhdDAQZr0ObZquka4paab235uxzTuvAifP83LOi9A9kDlATJ_6Zhys-poTQiIyp4TEF2jqP2gAFMglmhISQsDDMJygm2H49FwcJ_E1mgCLKCcRnSKZNwpn3VYbp7pBd3i1wlkOeKOk6p2x-N3ZvXR7q4JMOv2l3YgXxlrVFk6bbsBecT5irbeNw6bGm8ZUpj8k_Zm36Kou2kHdnd4Z-lg-54vXYP32slpk66ChJHVBmZY8BV7KigKVUZLEHAASVhdMQsXqqo4KEiek4iB5xGQaRVCnPCwI-Alj4Qw9HHP7fblTleit3hV2FOdrPfB4BBq_7be2Shwq1KY121Gc2hQpE1T4mjzN_qeX-7bN1Y87a2dL9FUd_gL7QX0K</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Oliveira, Laerte ; Costa-Neto, Claudio M ; Nakaie, Clovis R ; Schreier, Shirley ; Shimuta, Suma I ; Paiva, Antonio C. M</creator><creatorcontrib>Oliveira, Laerte ; Costa-Neto, Claudio M ; Nakaie, Clovis R ; Schreier, Shirley ; Shimuta, Suma I ; Paiva, Antonio C. M</creatorcontrib><description>Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto; and Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil The most prevalent physiological effects of ANG II, the main product of the renin-angiotensin system, are mediated by the AT 1 receptor, a rhodopsin-like AGPCR. Numerous studies of the cardiovascular effects of synthetic peptide analogs allowed a detailed mapping of ANG II's structural requirements for receptor binding and activation, which were complemented by site-directed mutagenesis studies on the AT 1 receptor to investigate the role of its structure in ligand binding, signal transduction, phosphorylation, binding to arrestins, internalization, desensitization, tachyphylaxis, and other properties. The knowledge of the high-resolution structure of rhodopsin allowed homology modeling of the AT 1 receptor. The models thus built and mutagenesis data indicate that physiological (agonist binding) or constitutive (mutated receptor) activation may involve different degrees of expansion of the receptor's central cavity. Residues in ANG II structure seem to control these conformational changes and to dictate the type of cytosolic event elicited during the activation. 1 ) Agonist aromatic residues (Phe 8 and Tyr 4 ) favor the coupling to G protein, and 2 ) absence of these residues can favor a mechanism leading directly to receptor internalization via phosphorylation by specific kinases of the receptor's COOH-terminal Ser and Thr residues, arrestin binding, and clathrin-dependent coated-pit vesicles. On the other hand, the NH 2 -terminal residues of the agonists ANG II and [Sar 1 ]-ANG II were found to bind by two distinct modes to the AT 1 receptor extracellular site flanked by the COOH-terminal segments of the EC-3 loop and the NH 2 -terminal domain. Since the [Sar 1 ]-ligand is the most potent molecule to trigger tachyphylaxis in AT 1 receptors, it was suggested that its corresponding binding mode might be associated with this special condition of receptors. 1 The online version of this article has supplemental data.</description><identifier>ISSN: 0031-9333</identifier><identifier>EISSN: 1522-1210</identifier><identifier>DOI: 10.1152/physrev.00040.2005</identifier><identifier>PMID: 17429042</identifier><language>eng</language><publisher>United States: Am Physiological Soc</publisher><subject>Animals ; Humans ; Receptor, Angiotensin, Type 1 - chemistry ; Receptor, Angiotensin, Type 1 - metabolism ; Renin-Angiotensin System - physiology ; Rhodopsin - chemistry ; Structure-Activity Relationship</subject><ispartof>Physiological reviews, 2007-04, Vol.87 (2), p.565</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17429042$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oliveira, Laerte</creatorcontrib><creatorcontrib>Costa-Neto, Claudio M</creatorcontrib><creatorcontrib>Nakaie, Clovis R</creatorcontrib><creatorcontrib>Schreier, Shirley</creatorcontrib><creatorcontrib>Shimuta, Suma I</creatorcontrib><creatorcontrib>Paiva, Antonio C. M</creatorcontrib><title>The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure</title><title>Physiological reviews</title><addtitle>Physiol Rev</addtitle><description>Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto; and Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil The most prevalent physiological effects of ANG II, the main product of the renin-angiotensin system, are mediated by the AT 1 receptor, a rhodopsin-like AGPCR. Numerous studies of the cardiovascular effects of synthetic peptide analogs allowed a detailed mapping of ANG II's structural requirements for receptor binding and activation, which were complemented by site-directed mutagenesis studies on the AT 1 receptor to investigate the role of its structure in ligand binding, signal transduction, phosphorylation, binding to arrestins, internalization, desensitization, tachyphylaxis, and other properties. The knowledge of the high-resolution structure of rhodopsin allowed homology modeling of the AT 1 receptor. The models thus built and mutagenesis data indicate that physiological (agonist binding) or constitutive (mutated receptor) activation may involve different degrees of expansion of the receptor's central cavity. Residues in ANG II structure seem to control these conformational changes and to dictate the type of cytosolic event elicited during the activation. 1 ) Agonist aromatic residues (Phe 8 and Tyr 4 ) favor the coupling to G protein, and 2 ) absence of these residues can favor a mechanism leading directly to receptor internalization via phosphorylation by specific kinases of the receptor's COOH-terminal Ser and Thr residues, arrestin binding, and clathrin-dependent coated-pit vesicles. On the other hand, the NH 2 -terminal residues of the agonists ANG II and [Sar 1 ]-ANG II were found to bind by two distinct modes to the AT 1 receptor extracellular site flanked by the COOH-terminal segments of the EC-3 loop and the NH 2 -terminal domain. Since the [Sar 1 ]-ligand is the most potent molecule to trigger tachyphylaxis in AT 1 receptors, it was suggested that its corresponding binding mode might be associated with this special condition of receptors. 1 The online version of this article has supplemental data.</description><subject>Animals</subject><subject>Humans</subject><subject>Receptor, Angiotensin, Type 1 - chemistry</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>Renin-Angiotensin System - physiology</subject><subject>Rhodopsin - chemistry</subject><subject>Structure-Activity Relationship</subject><issn>0031-9333</issn><issn>1522-1210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF1LwzAUhoMobk7_gBeSe-nMST_SXJbhdDAQZr0ObZquka4paab235uxzTuvAifP83LOi9A9kDlATJ_6Zhys-poTQiIyp4TEF2jqP2gAFMglmhISQsDDMJygm2H49FwcJ_E1mgCLKCcRnSKZNwpn3VYbp7pBd3i1wlkOeKOk6p2x-N3ZvXR7q4JMOv2l3YgXxlrVFk6bbsBecT5irbeNw6bGm8ZUpj8k_Zm36Kou2kHdnd4Z-lg-54vXYP32slpk66ChJHVBmZY8BV7KigKVUZLEHAASVhdMQsXqqo4KEiek4iB5xGQaRVCnPCwI-Alj4Qw9HHP7fblTleit3hV2FOdrPfB4BBq_7be2Shwq1KY121Gc2hQpE1T4mjzN_qeX-7bN1Y87a2dL9FUd_gL7QX0K</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Oliveira, Laerte</creator><creator>Costa-Neto, Claudio M</creator><creator>Nakaie, Clovis R</creator><creator>Schreier, Shirley</creator><creator>Shimuta, Suma I</creator><creator>Paiva, Antonio C. M</creator><general>Am Physiological Soc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20070401</creationdate><title>The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure</title><author>Oliveira, Laerte ; Costa-Neto, Claudio M ; Nakaie, Clovis R ; Schreier, Shirley ; Shimuta, Suma I ; Paiva, Antonio C. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h208t-b8b9819bcd212c4665911167fa7c1d7fdf4a0560d91c947c8441f893a0191c773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Receptor, Angiotensin, Type 1 - chemistry</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>Renin-Angiotensin System - physiology</topic><topic>Rhodopsin - chemistry</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oliveira, Laerte</creatorcontrib><creatorcontrib>Costa-Neto, Claudio M</creatorcontrib><creatorcontrib>Nakaie, Clovis R</creatorcontrib><creatorcontrib>Schreier, Shirley</creatorcontrib><creatorcontrib>Shimuta, Suma I</creatorcontrib><creatorcontrib>Paiva, Antonio C. M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Physiological reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oliveira, Laerte</au><au>Costa-Neto, Claudio M</au><au>Nakaie, Clovis R</au><au>Schreier, Shirley</au><au>Shimuta, Suma I</au><au>Paiva, Antonio C. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure</atitle><jtitle>Physiological reviews</jtitle><addtitle>Physiol Rev</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>87</volume><issue>2</issue><spage>565</spage><pages>565-</pages><issn>0031-9333</issn><eissn>1522-1210</eissn><abstract>Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo; Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto; and Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil The most prevalent physiological effects of ANG II, the main product of the renin-angiotensin system, are mediated by the AT 1 receptor, a rhodopsin-like AGPCR. Numerous studies of the cardiovascular effects of synthetic peptide analogs allowed a detailed mapping of ANG II's structural requirements for receptor binding and activation, which were complemented by site-directed mutagenesis studies on the AT 1 receptor to investigate the role of its structure in ligand binding, signal transduction, phosphorylation, binding to arrestins, internalization, desensitization, tachyphylaxis, and other properties. The knowledge of the high-resolution structure of rhodopsin allowed homology modeling of the AT 1 receptor. The models thus built and mutagenesis data indicate that physiological (agonist binding) or constitutive (mutated receptor) activation may involve different degrees of expansion of the receptor's central cavity. Residues in ANG II structure seem to control these conformational changes and to dictate the type of cytosolic event elicited during the activation. 1 ) Agonist aromatic residues (Phe 8 and Tyr 4 ) favor the coupling to G protein, and 2 ) absence of these residues can favor a mechanism leading directly to receptor internalization via phosphorylation by specific kinases of the receptor's COOH-terminal Ser and Thr residues, arrestin binding, and clathrin-dependent coated-pit vesicles. On the other hand, the NH 2 -terminal residues of the agonists ANG II and [Sar 1 ]-ANG II were found to bind by two distinct modes to the AT 1 receptor extracellular site flanked by the COOH-terminal segments of the EC-3 loop and the NH 2 -terminal domain. Since the [Sar 1 ]-ligand is the most potent molecule to trigger tachyphylaxis in AT 1 receptors, it was suggested that its corresponding binding mode might be associated with this special condition of receptors. 1 The online version of this article has supplemental data.</abstract><cop>United States</cop><pub>Am Physiological Soc</pub><pmid>17429042</pmid><doi>10.1152/physrev.00040.2005</doi></addata></record>
fulltext fulltext
identifier ISSN: 0031-9333
ispartof Physiological reviews, 2007-04, Vol.87 (2), p.565
issn 0031-9333
1522-1210
language eng
recordid cdi_highwire_physiology_physrev_87_2_565
source MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Humans
Receptor, Angiotensin, Type 1 - chemistry
Receptor, Angiotensin, Type 1 - metabolism
Renin-Angiotensin System - physiology
Rhodopsin - chemistry
Structure-Activity Relationship
title The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A56%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Angiotensin%20II%20AT1%20Receptor%20Structure-Activity%20Correlations%20in%20the%20Light%20of%20Rhodopsin%20Structure&rft.jtitle=Physiological%20reviews&rft.au=Oliveira,%20Laerte&rft.date=2007-04-01&rft.volume=87&rft.issue=2&rft.spage=565&rft.pages=565-&rft.issn=0031-9333&rft.eissn=1522-1210&rft_id=info:doi/10.1152/physrev.00040.2005&rft_dat=%3Cpubmed_highw%3E17429042%3C/pubmed_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/17429042&rfr_iscdi=true